Information Journal Paper
APA:
Copy. (2017). Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics-a decision analytical model. BJU International, 120(5), 659-665. SID. https://sid.ir/paper/723193/en
Vancouver:
Copy. Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics-a decision analytical model. BJU International[Internet]. 2017;120(5):659-665. Available from: https://sid.ir/paper/723193/en
IEEE:
Copy, “Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics-a decision analytical model,” BJU International, vol. 120, no. 5, pp. 659–665, 2017, [Online]. Available: https://sid.ir/paper/723193/en